Street Calls of the Week
Investing.com -- President Donald Trump will make an announcement regarding a U.S. drug pricing deal at the White House on Friday at 5 p.m., according to CBS News reporter Jennifer Jacobs.
The information was shared by Jacobs in a post on X, citing people familiar with the matter.
This announcement follows a recent agreement with Pfizer, which was announced last week. In that deal, Pfizer voluntarily agreed to implement measures ensuring Americans receive drug prices comparable to those in other developed countries.
The Pfizer agreement includes pricing newly launched medicines at parity with other key developed markets. The pharmaceutical company will also participate in a direct purchasing platform called TrumpRx.gov, allowing American patients to purchase medicines at significant discounts.
Under the Pfizer arrangement, the majority of the company’s primary care treatments and select specialty brands will be offered with savings ranging as high as 85% and averaging 50%.
The White House has not yet released details about which pharmaceutical companies might be involved in Friday’s announcement.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.